News Search Results
Sep 16, 2025, 12:05 ET Inari Announces New Chief Commercial Officer, Rob Dunlop
Dunlop brings more than 30 years of experience, spanning agribusiness, breeding, agronomy and biotechnology. He most recently served as Vice President, North America Seed at Nutrien Ag Solutions, with additional senior leadership roles at Bayer Crop Science
More news about: Inari
Sep 16, 2025, 11:14 ET Sanguine Expands Oncology Biospecimen Offerings Through Strategic Clinic Partnerships
and scientists working on innovative therapies. In supporting translational and clinical research at 30 of the top 40 global pharmaceutical and biotechnology companies, Sanguine has accelerated R&D and increased confidence in drug development and manufacturing pipelines. For the past four years, Sanguine
More news about: Sanguine Biosciences
Sep 16, 2025, 10:34 ET Asia New Vision Forum 2025 Opens in Singapore, Gathers Global Leaders to Chart the Future Amid Uncertainty
topics like geopolitics and financial markets and diverse dialogues on the key growth engines, namely, frontiers in artificial intelligence and biotechnology, urgent demands of the energy transition, and the future of advanced manufacturing and consumption. Senior executives from leading biotech, pharmaceutical,
More news about: Caixin
Sep 16, 2025, 10:30 ET Lilly announces plans to build $5 billion manufacturing facility in Virginia
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Sep 16, 2025, 10:30 ET Connected Health Market is Projected To Reach US$421.5 Billion By 2031 With CAGR of 6.5% During 2025-2031 | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Sep 16, 2025, 10:17 ET Solid-State Battery Market Size & Share to Surpass $56.05 Billion by 2035, Growing at a CAGR 42.5% | A Strategic Inflection Point for EVs, Energy Security, and Next-Gen Electronics
market research reports and actionable intelligence across healthcare, biotechnology, and advanced cell therapies. Our globally recognized insights empower stakeholders to make informed decisions, anticipate trends, and capitalize
More news about: Vantage Market Research
Sep 16, 2025, 10:02 ET Connect Life Sciences Announces Scott Dalton as New CEO
Scott Dalton as Chief Executive Officer. CLS is a leading provider of workforce solutions serving the pharmaceutical, biotechnology, and medical device industries.
More news about: Argosy Healthcare Partners
Sep 16, 2025, 10:01 ET Cybersecurity Market Is Projected To Reach US$552.35 Billion By 2031 With CAGR Of 13.8% | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Sep 16, 2025, 10:00 ET Roche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App integration, offering an enhanced diabetes management experience
Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world's largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics
More news about: Roche
Sep 16, 2025, 10:00 ET Roche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App integration, offering an enhanced diabetes management experience
Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world's largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics
More news about: Roche
Sep 16, 2025, 09:55 ET Unlocking the Body's Natural Healing Power: New Publication Reveals Breakthroughs in Regenerative Medicine
Dr. Sand, a biotechnology and regenerative medicine consultant with more than two decades of experience, reviewed in the publication a broad spectrum of clinical studies
More news about: QC Kinetix
Sep 16, 2025, 09:07 ET NUTRAFOL LAUNCHES 'THE MENOPAUSE EDIT' TO RECLAIM THE NARRATIVE AROUND MENOPAUSE AND HAIR HEALTH
formulations. To remain on the cutting edge of innovation, Nutrafol's team of doctors and researchers continues to explore breakthroughs in genetics, biotechnology, and anti-aging. Today, Nutrafol has been adopted by over 7,500 hair care and healthcare providers5 nationwide for its trusted,
More news about: Nutrafol
Sep 16, 2025, 09:00 ET ExSight Ventures Invests in RevOpsis Therapeutics to Advance Innovative Treatments for Blinding Eye Diseases
capital firm dedicated to investing in transformative ophthalmology innovations, today announced its investment in RevOpsis Therapeutics, a biotechnology company pioneering next-generation therapies for retinal diseases.
More news about: RevOpsis
Sep 16, 2025, 09:00 ET EndoCyclic Therapeutics Awarded Rare NIH "Perfect 10" Grant for Endometriosis Therapeutic
and transformative solution for women living with endometriosis". About EndoCyclic Therapeutics EndoCyclic Therapeutics is a biotechnology company focused on advancing groundbreaking solutions in women's health. Its lead program, ENDO-205, is the first non-hormonal, disease-modifying
More news about: EndoCyclic Therapeutics
Sep 16, 2025, 08:01 ET Precision Medicine Group Announces Appointment of Tracey Leahy as Chief People Officer
prioritize our team's experience and growth, ensuring we remain the employer of choice for top life science professionals and the partner of choice to biotechnology and pharmaceutical companies worldwide." About Tracey Leahy, Chief People Officer of Precision Medicine
More news about: Precision Medicine Group
Sep 16, 2025, 08:00 ET Coya Therapeutics' COYA 303 Shows Promising Central Nervous System (CNS) Anti-inflammatory Effects and Systemic Regulatory T Cell (Treg) Enhancing Effects in a Preclinical Animal Inflammation Model
Sept. 16, 2025 /PRNewswire/ -- Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, today announced results of a study designed to evaluate the
More news about: Coya Therapeutics, Inc.
Sep 16, 2025, 07:51 ET GCS LAUNCHES ADVANCED AUTOMATED CLEANROOM PANEL MANUFACTURING LINE IN THE U.S.
million sq. ft. of cleanroom paneling annually, supporting accelerated project timelines and precision manufacturing across the pharmaceutical, biotechnology, semiconductor, and advanced manufacturing industries. "It is incredibly rewarding to see our investment and hard work come to life through
More news about: G-CON Manufacturing
Sep 16, 2025, 07:30 ET Yasir Al-Wakeel Appointed CEO of Vesalius Therapeutics and CEO-Partner of Flagship Pioneering
Dr. Al-Wakeel joins Vesalius from multiple prior executive leadership roles guiding the growth of early- and growth-stage biotechnology companies. Previously, he served in senior roles as a biotech equity analyst and in corporate finance, where he was involved in more than
More news about: Flagship Pioneering
Sep 16, 2025, 07:00 ET AllRock Bio Announces $50 Million Series A to Advance Lead Clinical Program for Pulmonary Hypertension
Mass., Sept. 16, 2025 /PRNewswire/ -- AllRock Bio Inc., a clinical-stage biotechnology company focused on advancing therapies for cardiopulmonary and fibrotic diseases, today announced a $50 million Series
More news about: AllRock Bio
Sep 16, 2025, 07:00 ET K36 Therapeutics Provides Clinical Update on KTX-1001 in Multiple Myeloma
K36 Therapeutics, Inc. ("K36"), a privately held clinical-stage biotechnology company developing novel, targeted therapies for cancers with unmet medical need, today provided a clinical update on its lead asset, KTX-1001 for
More news about: K36 Therapeutics
Sep 16, 2025, 07:00 ET Dualitas Launches With $65 Million Series A to Advance Novel Bispecific Antibody Pipeline in Immune and Inflammatory Disease
compelling activity that monospecific agents cannot achieve. About Dualitas Therapeutics Dualitas Therapeutics, Inc. is a biotechnology company pioneering next-generation bispecific antibody (BsAb) therapies for immunology and inflammation (I&I). Dualitas' portfolio, built from
More news about: Dualitas Therapeutics
Sep 16, 2025, 07:00 ET Oncolytics Biotech® Provides Update on GOBLET Study Progress and U.S. Site Expansion
gastrointestinal tumors where patients desperately need treatment options." About Oncolytics Biotech Inc. Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered double-stranded RNA immunotherapeutic agent. Pelareorep has demonstrated promising results
More news about: Oncolytics Biotech® Inc.
Sep 16, 2025, 07:00 ET Novella Launches Potent Whole-Cell Strawberry Ingredient at SSW
About NovellaNovella Innovative Technology, Ltd. is a biotechnology company pioneering fruit- and vegetable-derived cell complexes for clean, intelligent, and sustainable wellness solutions. Leveraging its proprietary
More news about: Novella
Sep 16, 2025, 05:45 ET BIOVAXYS ANNOUNCES CLOSING OF UNSECURED CONVERTIBLE DEBENTURE OFFERING
receive the required regulatory approvals. With regards to BioVaxys' business, there are a number of risks that could affect the development of its biotechnology products, including, without limitation, the need for additional capital to fund clinical trials, its lack of operating history, uncertainty about
More news about: BioVaxys Technology Corp.
Sep 15, 2025, 16:30 ET WesternU researchers show Osteopathic Manipulative Treatment improves efficacy of COVID-19 vaccine
Calif. and Lebanon, Ore., is an independent nonprofit health professions university, conferring degrees in biotechnology and pharmaceutical sciences, dental medicine, medical sciences, nursing, optometry, osteopathic medicine, pharmacy, physical therapy, physician
More news about: Western University of Health Sciences